Risk factors for NE severity included incontinence symptoms, poor flow, increased bladder sensation, detrusor overactivity and underactivity
The US Food and Drug Administration ordered manufacturers of transvaginal mesh kits to discontinue sales and distribution in 2019.
Investigators identified the association among community-dwelling adults aged 60 years or older enrolled in the Baltimore Longitudinal Study of Aging.
A study of patients older than 70 years who had overactive bladder found that the vast major of them reported improvement urinary incontinence, urinary urgency, daytime urinary frequency, and nighttime frequency after intradetrusor injection of onabotulinumtoxinA.
BDNF proteolysis imbalance may be a potential biomarker and therapeutic target, new findings suggest.
The risk for these surgeries was negligible among never-pregnant women.
Observational study suggests symptoms of urinary urge incontinence reduced in postmenopausal women using prasterone
Survey of nursing directors shows impact on residents, staff, including turnover
Investigators comment on the first US-based prevalence study of nocturnal polyuria that collected frequency volume diary data in a non-clinic population.
Patients claim implanted mesh caused them pain, bleeding, infections, and required surgical removal